{Photo Credit: Health for All Project Staff}Photo Credit: Health for All Project Staff

From January 30 to February 7, 2018, Angola’s Health for All (HFA) Project, supported by the U.S. Agency for International Development (USAID), welcomed global health expert, Dr. Alaine Nyaruhirira, for a week-long training on the use of GeneXpert – technology that has become a game-changer in the fight against tuberculosis (TB).

We are pleased to announce that Dr. Jonathan D. Quick, MSH Senior Fellow Emeritus, has two articles in The Wall Street Journal and TIME Magazine. In his WSJ essay, “An Action Plan for Averting the Next Flu Pandemic,” Dr. Quick argues that we are not ready for the next flu pandemic and proposes the acceleration of a range of public-health measures, including work on a universal vaccine.

{Photo Credit: Liza Talukder}Jahidul Hasan works on the adverse drug event report.Photo Credit: Liza Talukder

The Directorate General of Drug Administration (DGDA)—with technical assistance from the USAID-funded SIAPS program, implemented by MSH—officially launched Bangladesh’s national pharmacovigilance (PV) program in 2013. After being first introduced at 20 private and public hospitals, and 13 pharmaceutical companies, the DGDA and SIAPS have organized trainings for focal persons to build their skills and knowledge on PV and increase adverse drug event (ADE) reporting.


Printer Friendly Version